Radiosurgery in the treatment of malignant brain tumors

Expert Review of Anticancer Therapy

Volumn 3, Issue 6, 2003, Pages 879-890

  Šimonová, Gabriela ^a   Roman, Liscák ^a  

^a NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Brain metastases; High grade glioma; Leksell gamma knife; Local tumor control; Low grade glioma; Malignant brain tumor; Prognostic factor; Radiosurgery; Survival; Uveal melanoma

Indexed keywords

AGE; BRAIN CANCER; BRAIN METASTASIS; BREAST CANCER; CANCER CONTROL; CANCER REGRESSION; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GAMMA KNIFE RADIOSURGERY; GENDER; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MELANOMA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RADIATION DOSE; RADIOSURGERY; REVIEW; SURVIVAL TIME; UVEA MELANOMA; WHOLE BODY RADIATION;

EID: 0346328309     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.3.6.879     Document Type: Review

References (63)

1. Laws ER, Thapar K. Brain tumors. CA Cancer J. Clin. 43, 263-271 (1993).
2. Johnson JD, Young B. Demographics of brain metastasis. Neurosurg. Clin. North Am. 7, 337-344 (1996).
3. Pickren JW, Lopez G, Tzukadu Z et al. Brain metastases: an autopsy study. Cancer Treat. Symp. 2, 295-313 (1983).
4. Wen PY, Loeffler JS. Management of brain metastases. Oncology 13, 941-961 (1999).
5. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv. Neurol. 19, 579-592 (1978).
6. Flickinger JC, Kondziolka D, Lunsford LD et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int. J. Radiat. Oncol. Biol. Phys. 28, 797-802(1994).
7. Alexander E III, Moriarty TM, Davis RB et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J. Natl Cancer Inst. 87, 34-40 (1995).
8. Auchter RM, Lamond JP, Alexander E III et al. A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int. J. Radtiat. Oncol. Biol. Phys. 35, 27-35 (1996).
9. Kihlstrom L, Karlsson B, Lindquist C. Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotactic Funct. Neurosurg. 61(1), 45-50 (1993).
10. Mehta MP, Rozental JM, Levin AB et al. Defining the role of radiosurgery in the management of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 24, 619-625 (1992).
11. Fukuoka S, Seo Z, Takanashi S et al. Radiosurgery of brain metastases with Gamma knife. Stereotactic Funct. Neurosurg. 66(Suppl. 1), 193-200 (1996).
12. Rand RW, Jacques DB, Melbye RW et al. Gamma knife radiosurgery for metastasis brain tumors. Acta Neurochir. 63(Suppl.), 85-88 (1995).
13. Seung SK, Sneed P, McDermott M et al. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer 4, 103-109 (1998).
14. Gerosa M, Nicolato A, Foroni R. Gamma knife radiosurgery for brain metastases: a primary therapeutic option. J. Neurosurg. 97(Suppl. 5), 515-524 (2002).
15. Shiau CH, Sneed PK, Shu HK. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int. J. Radiat. Oncol. Biol. Phys. 37, 375-383 (1997).
16. Young RF. Radiosurgery for the treatment of brain metastases. Semin. Surg. Oncol. 14(1), 70-78 (1998).
17. Sperduto PW, Scott C, Anrews D et al. Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of Radiation Therapy Oncology Group Phase III study 95-08. Int. J. Radiat. Oncol. Biol. Phys. 54(2, Suppl. 1), 3 (2002).
18. Varlotto JM, Flickinger J, Niranjan A et al. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 57(2), 452-464 (2003).
19. Huang CHF, Kondziolka D, Flickinger JC. Stereotactic radiosurgery for brain metastases. J. Neurosurg. 91, 563-568 (1999.)
20. Noel G, Simon JM, Valery CHA, Cornu PH et al. Radiosurgery for brain metastasis: impact of CTV on local control. Radiother. Oncol. 68, 15-21 (2003).
21. Shehata MK, Young B, Reid B et al. Stereotactic radiosurgery (SRS) of 468 <2 cm: implications for SRS dose and whole brain radiation therapy (WBRT). Int. J. Radiat. Oncol. Biol. Phys. 34(3), 6477-754 (1996).
22. Shaw E, Scott C, Souhami L et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of Radiation Therapy Oncology Group Protocol 90-05. Int. J. Radiat. Oncol. Biol. Phys. 34, 647-654 (1996).
23. Souhami L, Scott C, Brachman E et al. Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT) with BCNU to RT with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM): report of RTOG 93-05 protocol. Int. J. Radiat. Oncol. Biol. Phys. 54(2, Suppl. 1), 94-95 (2002).
24. Baumert BC, Lutterbach J, Bernays R, Davis JB. Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. Radiother. Oncol. 67, 183-190 (2003).
25. Szeifert GT, Massager N, Brotchi J, Levivier M. Morphological redifferentiation in a malignant astrocytic tumor after gamma knife radiosurgery. J. Neurosurg. 97(Suppl. 5), 627-630 (2002).
26. Saran FH, Baumert BG, Khoo VS et al. Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. Int. J. Radiat. Oncol. Biol. Phys. 53(1), 43-51 (2002).
27. Simonova G, Novotny J, Novotny J Jr, Vladyka V, Liscak R. Fractionated stereotactic radiotherapy with Leksell gamma knife: feasibility study. Radiother. Oncol. 37, 108-116 (1995).
28. Simonova G, Liscak R, Novotny J. Solitary brain metastases treated with Leksell gamma knife: prognostic factors for patients. Radiother. Oncol. 57, 207-213 (2000).
29. Gelblum DY, Lee H, Bilsky M. Radiographic findings and morbidity in patients treated with stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 42, 391-395 (1998).
30. Mori Z, Kondziolka D, Flickinger JC. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease. Int. J. Radiat. Oncol. Biol. Phys. 42(3), 581-589 (1998).
31. Young RF, Jacques D, Duma C. Gamma knife radiosurgery for treatment of multiple brain metastases: a comparison of patients with single versus multiple lesions. Radiosurgery 1, 92-101 (1996).
32. Nguyen LN, Moshe HM, Oswald MJ. Brain metastases as the only manifestation of an undetected primary tumor. Cancer 83(10), 2118-2183 (1998).
33. Coia L, Hanks GE, Martz K et al. Practice patterns of palliative care for United States 1984-1985. Int. J. Radiat. Oncol. Biol. Phys. 14, 1261-1269 (1988).
34. Patchel RA, Tibbs PA, Walsh JW. A randomized trial of surgery in the treatment of single metastases to the brain. N. Engl. J. Med. 322, 494-500 (1990).
35. Deborah DR, Speruto PW. Neuropsychological effects of cranial irradiation: current knowledge and future directions. Int. J. Radiat. Oncol. Biol. Phys. 31, 273-277 (1995).
36. Shaw E, Coffey RJ, Dinapoli RP. Neurotoxicity of radiosurgery. Semin. Radiat. Oncol. 5, 234-245 (1995).
37. Burger P, Byoko OB. Radiation injury to the nervous system. In: The Pathology of Central Nervous System Radiation Injury. Gutin P, Liebel S, Sheliene G (Eds), Raven Press, NY, USA, 191-208 (1991).
38. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology 39, 789-796 (1989).
39. Mintz AH, Kestle MP, Rathbone MP et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with single cerebral metastasis. Cancer 78, 1470-1476 (1996).
40. Bindal RK, Sawaya R, Leavens M. Surgical treatment of multiple brain metastases. J. Neurosurg. 79, 201-216 (1993).
41. Wronski M, Arbit E. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 85(8), 1677-1185 (1999).
42. Smalley SR, Laws ER, O'Faloon JR. Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients. J. Neurosurg. 77, 531-540 (1978).
43. Agboola O, Benoit B, Cross P. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 42(1), 155-159 (1998).
44. Mori Y, Kondziolka D, Flickinger J. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma. Cancer 83(2), 344-353 (1998).
45. Sanghavi SN, Miranpuri S, Chappell R et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by RTOG recursive partitioning analysis method. Int. J. Radiat. Oncol. Biol. Phys. 51(2), 426-434 (2001).
46. Brenner DJ, Hall EJ. Stereotactic radiotherapy of intracranial tumors: an ideal candidate for accelerated treatment. Int. J. Radiat. Oncol. Biol. Phys. 28, 1039-1041 (1994).
47. Hall EJ, Brener DJ. The radiobiology of radiosurgery: rationale for different treatment regimens for AVMs and malignancies. Int. J. Radiat. Oncol. Biol. Phys. 25, 381-385 (1993).
48. Steel G. Basic Clinical Radiobiology. Edward Arnold Publishers, London, UK, 55-129 (1993).
49. Jones B, Dale RG, Deehan C et al. The role of biology effective dose (BDE) in clinical oncology. Clin. Oncol. 13, 71-81 (2002).
50. Bhatnagar A, Heron DE, Kondziolka D et al. Analysis of repeat stereotactic radiosurgery for progressive primary and metastatic CNS tumors. Int. J. Radiat. Oncol. Biol. Phys. 53, 527-532 (2002).
51. Haken RKT, Fraass BA, Lichtar AS et al. A brain tumor dose escalation protocol based on effective dose equivalence to prior experience. Int. J. Radiat. Oncol. Biol. Phys. 42(1), 137-141 (1998).
52. Kondziolka D, Patel A, Lunsford LD et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 45(2), 427-434 (1999).
53. Sneed PK, Lamborn KR, Forstner JM. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int. J. Radiat. Oncol. Biol. Phys. 43, 549-558 (1999).
54. Kondziolka D, Patel A, Lunsford D, Kassam A, Flickinger J. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 45, 427-434 (1999).
55. Sperduto PW, Scott C, Andrews D et al. Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of Radiation Therapy Oncology Group Phase III study 95-08. Int. J. Radiat. Oncol. Biol. Phys. 54(2, Suppl. 1), 3 (2002).
56. No authors listed. LENT SOMA tables. Radiother. Oncol. 35(1), 17-60 (1995).
57. Noordijk EM, Vecht CJ, Haxma-Reiche H. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int. J. Radiat. Oncol. Biol. Phys. 29, 711-717 (1994).
58. Gaspar L, Scott CH, Rotman M. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 37, 745-751 (1997).
59. Cho KH, Hall WA, Gerbi BJ. Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery. J. Neurooncol. 40(1), 73-86 (1998).
60. McAleese JJ, Stenning SP, Ashley S, Traish D et al. Hypofractionated radiotherapy for poor prognosis malignant glioma: matched pair survival analysis with MRC controls. Radiother. Oncol. 67, 177-182 (2003).
61. Boethius J, Ulfarsson E, Rahn T, Lippittz B. Gamma knife radiosurgery for pilocytic astrocytomas. J. Neurosurg. 97(Suppl. 5), 677-680 (2002).
62. Zehetmayer M. Local tumor control and morbidity after one to three fractions stereotactic external beam irradiation for uveal melanoma. Radiother. Oncol. 55, 135-144 (2000).
63. Simonova G, Novotny J, Liscak R. Leksell gamma knife treatment of uveal melanoma. J. Neurosurg. 97(Suppl. 5), 635-639(2002).